mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.02 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
XAV-939 |
GDSC1000 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.03 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.03 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.04 |